These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10675700)

  • 41. Application of percolation theory in the study of an extended release Verapamil hydrochloride formulation.
    Gonçalves-Araújo T; Rajabi-Siahboomi AR; Caraballo I
    Int J Pharm; 2008 Sep; 361(1-2):112-7. PubMed ID: 18621491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation between the viscoelastic properties of the gel layer of swollen HPMC matrix tablets and their in vitro drug release.
    Hamed R; Al Baraghthi T; Sunoqrot S
    Pharm Dev Technol; 2018 Nov; 23(9):838-848. PubMed ID: 27808590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erosion characteristics of an erodible tablet incorporated in a time-delayed capsule device.
    McConville JT; Ross AC; Florence AJ; Stevens HN
    Drug Dev Ind Pharm; 2005 Jan; 31(1):79-89. PubMed ID: 15704859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Direct measurement of the time-dependent mechanical response of HPMC and PEO compacts during swelling.
    Hewlett KO; L'Hote-Gaston J; Radler M; Shull KR
    Int J Pharm; 2012 Sep; 434(1-2):494-501. PubMed ID: 22609126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study of the critical points and the role of the pores and viscosity in carbamazepine hydrophilic matrix tablets.
    Aguilar-de-Leyva A; Cifuentes C; Rajabi-Siahboomi AR; Caraballo I
    Eur J Pharm Biopharm; 2012 Jan; 80(1):136-42. PubMed ID: 21946473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
    Quinten T; De Beer T; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design of floating bilayer tablets of diltiazem hydrochloride and lovastatin.
    Kulkarni AS; Bhatia MS
    PDA J Pharm Sci Technol; 2008; 62(5):344-52. PubMed ID: 19055230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type.
    Shojaee S; Kaialy W; Cumming KI; Nokhodchi A
    Pharm Dev Technol; 2016 Mar; 21(2):189-95. PubMed ID: 25410967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of water soluble fillers in hydroxypropylmethylcellulose matrices on in vitro and in vivo drug release.
    Sako K; Sawada T; Nakashima H; Yokohama S; Sonobe T
    J Control Release; 2002 May; 81(1-2):165-72. PubMed ID: 11992689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and evaluation of a multiple-unit oral sustained release dosage form for S(+)-ibuprofen: preparation and release kinetics.
    Cox PJ; Khan KA; Munday DL; Sujja-areevath J
    Int J Pharm; 1999 Dec; 193(1):73-84. PubMed ID: 10581424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and release mechanism of diltiazem HCl prolonged release matrix tablets.
    Boyapally H; Nukala RK; Douroumis D
    Drug Deliv; 2009 Feb; 16(2):67-74. PubMed ID: 19267297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A predictive model for the release of slightly water-soluble drugs from HPMC matrices.
    Fu XC; Wang GP; Wang YH; Liang WQ
    Pharmazie; 2004 Aug; 59(8):624-6. PubMed ID: 15378852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of HPMC viscosity as FRC parameter on the release of low soluble drug from hydrophylic matrix tablets.
    Novak SD; Kuhelj V; Vrečer F; Baumgartner S
    Pharm Dev Technol; 2013; 18(2):343-7. PubMed ID: 21916601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of HPMC particle size on the drug release rate and the percolation threshold in extended-release mini-tablets.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2015 Jan; 41(1):70-8. PubMed ID: 24134563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Release of diltiazem hydrochloride from hydrophilic matrices of polyethylene oxide and carbopol.
    Varma M; Singla AK; Dhawan S
    Drug Dev Ind Pharm; 2004 May; 30(5):545-53. PubMed ID: 15244090
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Formulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M.
    Qazi F; Shoaib MH; Yousuf RI; Qazi TM; Mehmood ZA; Hasan SM
    Pak J Pharm Sci; 2013 Jul; 26(4):653-63. PubMed ID: 23811439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of FITC-dextran molecular weight on its release from floating cetyl alcohol and HPMC tablets.
    Xu G; Groves MJ
    J Pharm Pharmacol; 2001 Jan; 53(1):49-56. PubMed ID: 11206192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of dose and solubility of additives on the release from HPMC matrix tablets--identifying critical conditions.
    Tajarobi F; Abrahmsén-Alami S; Hansen M; Larsson A
    Pharm Res; 2009 Jun; 26(6):1496-503. PubMed ID: 19280323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In-vitro and in-vivo studies of the diclofenac sodium controlled-release matrix tablets.
    Liu CH; Kao YH; Chen SC; Sokoloski TD; Sheu MT
    J Pharm Pharmacol; 1995 May; 47(5):360-4. PubMed ID: 7494183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.